FACTORS CONTROLLING GRAFT-HOST INTERACTIONS
控制移植物-宿主相互作用的因素
基本信息
- 批准号:2136816
- 负责人:
- 金额:$ 17.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-05-01 至 1996-03-31
- 项目状态:已结题
- 来源:
- 关键词:MHC class I antigen bone marrow transplantation cell mediated lymphocytolysis test cytotoxic T lymphocyte fusion gene gene expression graft versus host disease histocompatibility immunogenetics immunoregulation laboratory mouse lymphokine activated killer cell major histocompatibility complex natural killer cells tissue /cell culture transfection
项目摘要
Natural resistance to hemopoietic allografts, in particular F1 hybrid
resistance to parental grafts, represents one of the most puzzling
immunological phenomena. The resistance is genetically specific, and is
largely controlled by recessive genes located within the major
histocompatibility complex (MHC). The effector mechanism, which requires
natural killer (NK) cells, is poorly understood. These properties are
unique, and need to be reconciled with the contemporary concepts of
cellular immunology and transplantation genetics. The long-term objective
of this research project is to elucidate the immunogenetic, cellular, and
ultimately molecular mechanisms underlying this form of natural
resistance.
This application focuses on the mechanisms by which the expression of the
Hh-l phenotype is regulated, particularly by MHC class I genes.
Preliminary experiments demonstrate that the expression of transfected H-
2Dd gene or cDNA, but not H-2Ld gene, in H-2b/Hh-lb cells converts the
cells into an Hh-lb negative phenotype, as tested in vivo. It is proposed
that this model is amenable to a detailed analysis of the
structural/functional requirement for the effect of Dd molecule on the Hh-
lb phenotype through the use of a series of artificially constructed or
naturally occurring Dd/Ld hybrid genes. These studies will determine the
specificity and the potential mechanism by which the class I molecule
alters the Hh-l phenotype, as opposed to the generalized effect of class
I products on the susceptibility of some cells to natural killing.
Further, the proposed study will test the hypothesis that the heterozygous
(H-2b x H-2d) cells fail to express Hh - 1b phenotype solely due to the
expression of the H - 2Dd molecule. Finally, in order to carry this
project into an analysis of the biochemical events underlying the
regulation of the Hh-l phenotype, an in vitro model of hybrid resistance
will be developed using as effectors the adherent IL-2-activated NK cells.
These studies should improve our understanding of the relationship between
the classic MHC genes and the Hh system and the mechanism that underlie
immune surveillance for hemopoietic neoplasms. These studies may also
suggest a means of reducing bone marrow allograft failure in man.
自然抵抗造血异体移植物,特别是F1杂交
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ICHIRO NAKAMURA其他文献
ICHIRO NAKAMURA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ICHIRO NAKAMURA', 18)}}的其他基金
GENETIC ANALYSIS OF HEMOPOIETIC HISTOCOMPATIBILITY
造血组织相容性的遗传分析
- 批准号:
3197272 - 财政年份:1991
- 资助金额:
$ 17.36万 - 项目类别:
GENETIC ANALYSIS OF HEMOPOIETIC HISTOCOMPATIBILITY
造血组织相容性的遗传分析
- 批准号:
3197273 - 财政年份:1991
- 资助金额:
$ 17.36万 - 项目类别:
GENETIC ANALYSIS OF HEMOPOIETIC HISTOCOMPATIBILITY
造血组织相容性的遗传分析
- 批准号:
2094790 - 财政年份:1991
- 资助金额:
$ 17.36万 - 项目类别:
IMMUNOBIOLOGY OF THE HEMOPOIETIC HISTOCOMPATIBILITY
造血组织相容性的免疫生物学
- 批准号:
3181778 - 财政年份:1986
- 资助金额:
$ 17.36万 - 项目类别:
IMMUNOBIOLOGY OF THE HEMOPOIETIC HISTOCOMPATIBILITY
造血组织相容性的免疫生物学
- 批准号:
3181776 - 财政年份:1986
- 资助金额:
$ 17.36万 - 项目类别:
IMMUNOBIOLOGY OF THE HEMOPOIETIC HISTOCOMPATIBILITY
造血组织相容性的免疫生物学
- 批准号:
3181777 - 财政年份:1986
- 资助金额:
$ 17.36万 - 项目类别:
相似海外基金
Prevention of age-related hearing loss using bone marrow transplantation
利用骨髓移植预防与年龄相关的听力损失
- 批准号:
23K08999 - 财政年份:2023
- 资助金额:
$ 17.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantation
调节酪氨酸激酶信号传导以改善造血干细胞扩增和骨髓移植
- 批准号:
2889841 - 财政年份:2023
- 资助金额:
$ 17.36万 - 项目类别:
Studentship
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation
使用靶向骨髓照射治疗镰状细胞病的新型骨髓移植方法
- 批准号:
10737358 - 财政年份:2023
- 资助金额:
$ 17.36万 - 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10722602 - 财政年份:2022
- 资助金额:
$ 17.36万 - 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10368246 - 财政年份:2022
- 资助金额:
$ 17.36万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10600143 - 财政年份:2022
- 资助金额:
$ 17.36万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10370775 - 财政年份:2022
- 资助金额:
$ 17.36万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10303678 - 财政年份:2021
- 资助金额:
$ 17.36万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10415200 - 财政年份:2021
- 资助金额:
$ 17.36万 - 项目类别:














{{item.name}}会员




